TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 11, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 4
- 0 vs. Q1 2021
- Portfolio value
- $210.1M
- −$61.4M (−22.6%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 8,008,204 | $78.3M | 37.3% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $62.1M | 29.6% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 1,419,900 | $45.1M | 21.5% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $24.6M | 11.7% | 00.0% | Unchanged | History |